Cepheid secures FDA EUA for rapid Covid-19 diagnostic test
Xpert Xpress CoV-2 plus is a rapid molecular diagnostic test designed to identify Covid-19 causing virus.
News
Latest in
News
US NIH licences Covid-19 technologies to WHO and MPP
The technologies include SARS-CoV-2 stabilised spike protein, early-stage vaccine and diagnostic candidates, and research tools.
GE Healthcare to invest in Pulsenmore to enter homecare segment
GE will collaborate with Pulsenmore to supply its products in Europe and various other markets.
Rehabtronics announces availability of ReGrasp Bionic Glove in US
The FDA-cleared ReGrasp Bionic Glove can be used to improve hand function after stroke or injury.
Babson and BD expand collaboration for new blood collection settings
Under the alliance, the companies also intend to develop diagnostic tests for paediatric usage.
Inex receives CE-IVD mark for ovarian cancer rapid test
The point-of-care test can distinguish benign from malignant ovarian cysts in an operating theatre setting.
Filterlex concludes first-in-human study of CAPTIS device
The CAPTIS device is designed to lessen the risk of stroke and other complications during catheter-based heart surgeries.
Hologic secures US FDA approval for Aptima CMV Quant assay
The Aptima CMV Quant assay was approved to quantify the viral load of CMV among transplant recipients.